Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vandenberghe

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Leukemia|February 20, 2003
Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantationP Vandenberghe, N Boeckx, E Ronsyn, et al.
British Journal of Haematology|June 1, 1995
Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single-dose cyclophosphamide combined with rhGM-CSF or rhG-CSFH Demuynck, M Delforge, G Verhoef, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2018
Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patientsL De Roeck, L Michaux, K Debackere, et al.
Leukemia|February 4, 2012
Ponatinib is active against imatinib-resistant mutants of FIP1L1-PDGFRA and KIT, and against FGFR1-derived fusion kinasesE Lierman, S Smits, J Cools, et al.
International Immunology|March 1, 1993
In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical studyP Vandenberghe, J Delabie, M de Boer, et al.
Annals of Hematology|July 1, 1995
An update on peripheral blood progenitor cell transplantationH Demuynck, M Delforge, P Zachée, et al.
Annals of Hematology|November 1, 1996
Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndromeP Vandenberghe, P Zachee, S Verstraete, et al.
European Journal of Immunology|December 1, 1993
Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cellsM de Boer, A Kasran, J Kwekkeboom, et al.
Leukemia|February 13, 2009
FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenibE Lierman, L Michaux, E Beullens, et al.
Archives of Dermatological Research|September 23, 2000
In situ expression of the CTLA-4 receptor in T-cell-mediated inflammatory and neoplastic skin diseasesM Alaibac, A Belloni Fortina, A Poletti, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Leukemia|February 20, 2003
Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantationP Vandenberghe, N Boeckx, E Ronsyn, et al.
British Journal of Haematology|June 1, 1995
Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single-dose cyclophosphamide combined with rhGM-CSF or rhG-CSFH Demuynck, M Delforge, G Verhoef, et al.
Hematology (Amsterdam, Netherlands)|July 12, 2018
Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patientsL De Roeck, L Michaux, K Debackere, et al.
Leukemia|February 4, 2012
Ponatinib is active against imatinib-resistant mutants of FIP1L1-PDGFRA and KIT, and against FGFR1-derived fusion kinasesE Lierman, S Smits, J Cools, et al.
International Immunology|March 1, 1993
In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical studyP Vandenberghe, J Delabie, M de Boer, et al.
Annals of Hematology|July 1, 1995
An update on peripheral blood progenitor cell transplantationH Demuynck, M Delforge, P Zachée, et al.
Annals of Hematology|November 1, 1996
Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndromeP Vandenberghe, P Zachee, S Verstraete, et al.
European Journal of Immunology|December 1, 1993
Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cellsM de Boer, A Kasran, J Kwekkeboom, et al.
Leukemia|February 13, 2009
FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenibE Lierman, L Michaux, E Beullens, et al.
Archives of Dermatological Research|September 23, 2000
In situ expression of the CTLA-4 receptor in T-cell-mediated inflammatory and neoplastic skin diseasesM Alaibac, A Belloni Fortina, A Poletti, et al.
Pageof 11